Head & Neck
Genitourinary Radiology: Page 2
AI developed for staging patients with prostate cancer
An AI model based on prostate-specific membrane antigen-PET/CT imaging performs well in staging prostate cancer patients for surgery, according to a talk at the Society for Nuclear Medicine and Molecular Imaging meeting in Chicago.
July 2, 2023
SNMMI: Tailored prostate cancer treatment improves outcomes
Monitoring response during lutetium-177 prostate-specific membrane antigen radioligand therapy improves outcomes, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in Chicago.
June 27, 2023
Blue Earth highlights Posluma study results
Blue Earth Diagnostics, a Bracco company, is highlighting results from a study that explored the impact of urinary activity on the interpretation of its flotufolastat F-18 injection (Posluma).
June 26, 2023
SNMMI: PET tracer describes clear cell renal cancer
A new PET tracer can accurately detect and differentiate a certain type of kidney cancer from other kidney tumor types, according to research presented June 26 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 26, 2023
Avenda spotlights AI prostate cancer study
AI software developer Avenda Health is highlighting clinical results that suggest its Unfold AI imaging software is effective in prostate cancer patients.
June 13, 2023
ISMRM: Multiparametric MRI data interpretation varies among radiologists
TORONTO - Interpretation of multiparametric MRI (mpMRI) data for diagnosing prostate cancer can vary among radiologists, according to research presented June 5 at the International Society for Magnetic Resonance in Medicine (ISMRM) meeting.
June 6, 2023
CLS Americas receives first thermal therapy system order
Clinical Laserthermia Systems (CLS) Americas said it has received its first order of the company's Tranberg thermal therapy system and accessories from the National Institutes of Health Clinical Center.
May 31, 2023
PET/CT superior to scintigraphy for detecting metastatic bone cancer
PET/CT is more accurate than bone scintigraphy for detecting bone metastases in patients with prostate cancer, according to a study published May 20 in the
Journal of Medical Imaging and Radiation Sciences
May 30, 2023
Kidney ultrasound detects abnormalities in children with UTI
About one in five children with first febrile urinary tract infection (UTI) will have a urinary tract abnormality detected on ultrasound exams of the kidney, a Canadian meta-analysis published May 30 in
May 29, 2023
TeraRecon adds prostate cancer detection to its Eureka AI platform
ConcertAI's TeraRecon has added Bot Image's prostate cancer detection and diagnosis artificial intelligence (AI) software to its Eureka Clinical AI platform.
May 25, 2023
Delayed SPECT improves prostate cancer detection
Delaying SPECT/CT imaging by 15 hours after radiotracer injection can enable the identification of more tumors in patients with relapsed prostate cancer, according to a study published May 25 in the
Journal of Nuclear Medicine
May 25, 2023
PSMA-PET/CT is cost-effective over standard prostate cancer imaging
A cost analysis has demonstrated that prostate-specific membrane antigen (PSMA)-PET/CT imaging with F-18 DCFPyL radiotracer should be considered as an alternative to standard imaging for prostate cancer staging, according to a group in New York.
May 24, 2023
Page 2 of 89